Sex and estradiol influence glial pro-inflammatory responses to lipopolysaccharide in rats - PubMed (original) (raw)
Sex and estradiol influence glial pro-inflammatory responses to lipopolysaccharide in rats
Lisa C Loram et al. Psychoneuroendocrinology. 2012 Oct.
Abstract
There is a greater prevalence of neuroinflammatory diseases in females than males. Microglia, the major immunocompetent cells of the central nervous system, play a key role in neuroinflammation. We aimed to determine if inherent differences in toll-like receptor 4 mediated pro-inflammatory response in glia could possibly contribute to the skewed female prevalence of neuroinflammatory disorders. In addition, in order to identify if estradiol (E2), the major female sex steroid contributes to a heightened pro-inflammatory response, estradiol was added both in vivo and in vitro. Microglia and astrocytes were isolated from neonatal pups and stimulated with lipopolysaccharide (LPS) in the presence and absence of E2. Hippocampal microglia were isolated from adult male and female rats and stimulated ex vivo with LPS. Male neonatal microglia and astrocytes produced greater IL-1β mRNA than females. However, when co-incubated with varying doses of estradiol (E2), the E2 produced anti-inflammatory effects in the male microglia but a pro-inflammatory effect in female microglia. LPS-induced IL-1β mRNA was attenuated by E2 in female but not male adult hippocampal microglia. However, females supplemented with E2 in vivo produced a potentiated IL-1β mRNA response. TLR4 mRNA was decreased by LPS in both microglia and astrocytes but was not affected by sex or E2. CD14 mRNA was increased by LPS and may be elevated more in females than males in microglia but not astrocytes. Therefore, sexual dimorphic differences do occur in both neonatal and adult microglia though maturity of the microglia at the time of isolation influences the pro-inflammatory response.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Figures
Figure 1
Neonatal male and female microglia isolated from P0/1 pups were incubated with 0, 1, 10 or 100ng/ml LPS for 4 h. IL-1β mRNA (A), MD2 mRNA (B), CD14 mRNA (C) and TLR4 mRNA (D) was measured. There was a significant LPS dose response on IL-1β mRNA and TLR4 mRNA suppression in male but not female microglia. Males produced a greater IL-1β mRNA response than females while females produced a greater CD14 mRNA response at the lowest dose of LPS. Data are expressed as mean ± SEM (n=9–12/gp). ** P<0.01 between groups. $ P<0.05 compared to other doses of LPS.
Figure 2
Neonatal microglia were isolated from male and female P0/1 pups and incubated with vehicle or 10ng/ml LPS and 0, 10 nM or 100 nM 17-β estradiol (E2) for 4 h. IL-1β, MD2, CD14 and TLR4 mRNA were measured. E2 had a significant effect on IL-1β mRNA in both male and female microglia. E2 potentiated the IL-1β mRNA response to LPS in females but attenuated the IL-1β mRNA response in the male microglia. Similar trends were identified in CD14 mRNA expression. There was no significant effect on MD2 mRNA expression, but TLR4 mRNA expression was suppressed by LPS in both sexes. Data are expressed as mean ± SEM (n=9–12/gp).* P<0.05, ** P<0.01, *** P<0.001 between groups on post-hoc comparisons.
Figure 3
Neonatal male and female astrocytes isolated from P0/1 pups were incubated with 0, 1, 10 and 100ng/ml LPS for 4 h and measured for IL-1β mRNA (A), MD2 mRNA(B), CD14 mRNA (C) and TLR4 mRNA (D). There was a significant LPS dose response on IL-1β mRNA and TLR4 mRNA in both male and female astrocytes. Males produced a greater IL-1β mRNA response than females. There was a significant effect of LPS on CD14 mRNA but no difference between the sexes. There was no significant effect on MD2 except in males at the high dose of LPS. Data are expressed as mean ± SEM (n=6/gp). * P<0.05 between groups.
Figure 4
Neonatal astrocytes isolated from male and female pups that were incubated with vehicle or 10 ng/ml LPS and 0, 10 nM or 100 nM 17-β estradiol (E2) for 4 h. IL-1β, MD2, CD14 and TLR4 mRNA was measured. E2 had no significant effect on IL-1β, MD2, CD14 or TLR4 mRNA in either male and female astrocytes. Data are expressed as mean ± SEM (n=6/gp).** P<0.01, *** P<0.001, between groups.
Figure 5
Rapidly isolated hippocampal microglia from adult male and OVX female rats were incubated with 0 or 100 ng/ml LPS and 0, 10 or 100 nM E2 for 3 h. IL-1β, MD2, CD14 and TLR4 mRNA from the cells was measured. There was significantly greater IL-1β and CD14 mRNA in males compared to females. E2 significantly suppressed the IL-1β mRNA response to LPS in female microglia. Females had significantly greater TLR4 mRNA than males. Data are expressed as mean ± SEM (n=6–8 per group). $ P<0.05 for main effect of sex, @ P<0.05 significant effect of LPS/E2 where indicated
Figure 6
Rapidly isolated hippocampal microglia from adult male and OVX ± E2 female rats were incubated with 0, 10 or 100 ng/ml LPS for 3 h. IL-1β, MD2, CD14 and TLR4 mRNA was measured. LPS significantly increased IL-1β and CD14 mRNA in all groups. Supplemented E2 in the OVX females significantly increased IL-1β mRNA compared to all other groups at both doses of LPS. There was a significant LPS dose response on CD14 mRNA, with males and females supplemented with E2 having the greatest CD14 mRNA expression. Females and males with E2 had significantly greater TLR4 mRNA in response to LPS compared to those not supplemented with E2. Data are expressed as mean ± SEM (n=6–10 per group). *** P<0.001 compared to all other groups at the same dose of LPS.
Similar articles
- Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
Marson AG, Burnside G, Appleton R, Smith D, Leach JP, Sills G, Tudur-Smith C, Plumpton CO, Hughes DA, Williamson PR, Baker G, Balabanova S, Taylor C, Brown R, Hindley D, Howell S, Maguire M, Mohanraj R, Smith PE. Marson AG, et al. Health Technol Assess. 2021 Dec;25(75):1-134. doi: 10.3310/hta25750. Health Technol Assess. 2021. PMID: 34931602 Clinical Trial. - Depressing time: Waiting, melancholia, and the psychoanalytic practice of care.
Salisbury L, Baraitser L. Salisbury L, et al. In: Kirtsoglou E, Simpson B, editors. The Time of Anthropology: Studies of Contemporary Chronopolitics. Abingdon: Routledge; 2020. Chapter 5. In: Kirtsoglou E, Simpson B, editors. The Time of Anthropology: Studies of Contemporary Chronopolitics. Abingdon: Routledge; 2020. Chapter 5. PMID: 36137063 Free Books & Documents. Review. - Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
Lee CC, Chen CW, Yen HK, Lin YP, Lai CY, Wang JL, Groot OQ, Janssen SJ, Schwab JH, Hsu FM, Lin WH. Lee CC, et al. Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23. Clin Orthop Relat Res. 2024. PMID: 39051924 - Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.
Pillay J, Gaudet LA, Saba S, Vandermeer B, Ashiq AR, Wingert A, Hartling L. Pillay J, et al. Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3. Syst Rev. 2024. PMID: 39593159 Free PMC article. - Progestogens for prevention of luteinising hormone (LH) surge in women undergoing controlled ovarian hyperstimulation as part of an assisted reproductive technology (ART) cycle.
Glujovsky D, Pesce R, Miguens M, Sueldo C, Ciapponi A. Glujovsky D, et al. Cochrane Database Syst Rev. 2023 Nov 30;11(11):CD013827. doi: 10.1002/14651858.CD013827.pub2. Cochrane Database Syst Rev. 2023. PMID: 38032057 Free PMC article. Review.
Cited by
- Acute brain injury and nanomedicine: sex as a biological variable.
Simmons A, Mihalek O, Bimonte Nelson HA, Sirianni RW, Stabenfeldt SE. Simmons A, et al. Front Biomater Sci. 2024;3:1348165. doi: 10.3389/fbiom.2024.1348165. Epub 2024 Feb 2. Front Biomater Sci. 2024. PMID: 39450372 Free PMC article. - Inflammaging and Brain Aging.
Jurcau MC, Jurcau A, Cristian A, Hogea VO, Diaconu RG, Nunkoo VS. Jurcau MC, et al. Int J Mol Sci. 2024 Sep 30;25(19):10535. doi: 10.3390/ijms251910535. Int J Mol Sci. 2024. PMID: 39408862 Free PMC article. Review. - Microglial responses to inflammatory challenge in adult rats altered by developmental exposure to polychlorinated biphenyls in a sex-specific manner.
Walker KA, Rhodes ST, Liberman DA, Gore AC, Bell MR. Walker KA, et al. Neurotoxicology. 2024 Sep;104:95-115. doi: 10.1016/j.neuro.2024.07.009. Epub 2024 Jul 20. Neurotoxicology. 2024. PMID: 39038526 - Essential Oil Constituents as Anti-Inflammatory and Neuroprotective Agents: An Insight through Microglia Modulation.
Stojanović NM, Ranđelović PJ, Simonović M, Radić M, Todorović S, Corrigan M, Harkin A, Boylan F. Stojanović NM, et al. Int J Mol Sci. 2024 May 9;25(10):5168. doi: 10.3390/ijms25105168. Int J Mol Sci. 2024. PMID: 38791205 Free PMC article. Review. - 4R-cembranoid suppresses glial cells inflammatory phenotypes and prevents hippocampal neuronal loss in LPS-treated mice.
Rojas-Colón LA, Redell JB, Dash PK, Vegas PE, Vélez-Torres W. Rojas-Colón LA, et al. J Neurosci Res. 2024 Apr;102(4):e25336. doi: 10.1002/jnr.25336. J Neurosci Res. 2024. PMID: 38656664
References
- Achiron A, Gurevich M. Gender effects in relapsing-remitting multiple sclerosis: correlation between clinical variables and gene expression molecular pathways. J Neurol Sci. 2009;286:47–53. - PubMed
- Aloisi F. The role of microglia and astrocytes in CNS immune surveillance and immunopathology. Adv Exp Med Biol. 1999;468:123–133. - PubMed
- Azcoitia I, Santos-Galindo M, Arevalo MA, Garcia-Segura LM. Role of astroglia in the neuroplastic and neuroprotective actions of estradiol. Eur J Neurosci. 2010;32:1995–2002. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- DA024044/DA/NIDA NIH HHS/United States
- K05 DA024044-05/DA/NIDA NIH HHS/United States
- DE107782/DE/NIDCR NIH HHS/United States
- K05 DA024044/DA/NIDA NIH HHS/United States
- R01 DE017782-03/DE/NIDCR NIH HHS/United States
- R01 DA023132-05/DA/NIDA NIH HHS/United States
- DA023132/DA/NIDA NIH HHS/United States
- R01 DE017782/DE/NIDCR NIH HHS/United States
- R01 DE021966/DE/NIDCR NIH HHS/United States
- R01 DA023132/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Research Materials